Chlamydia Screening
2023-24 Edition
Why is it important to screen for Chlamydia?
Chlamydia is the most common bacterial sexually transmitted infection (STI) in the United States. If found early, Chlamydia can easily be treated and cured without complications. If left untreated, Chlamydia can cause serious infertility problems, which may keep women from getting pregnant.
How should doctors screen for Chlamydia?
Your doctor will do a lab test for Chlamydia as part of a pelvic exam. If you are a sexually active woman between the ages of 16 and 24, it is important that your doctor test you for the disease every year. Your doctor may also recommend that your sexual partner(s) be screened and treated if necessary.
Talk with your doctor and health plan to find out about what materials and other resources are available. Many health plans offer educational materials (print or online) about screening for Chlamydia and other sexually transmitted infections (STIs). These materials can help you to better understand the tests, the results and how to prevent STIs.
What do the stars mean?
The scores show how well each health plan did at making sure sexually active women aged 16 through 24 years were tested for Chlamydia. A higher score means more women got the right care at the right time.
The scores are based on information from at least 30 health plan member administrative records in 2022.
Data Disclaimer
The data source for data for the Report Cards is Quality Compass® 2023 and is used with the permission of the National Committee for Quality Assurance (NCQA). Quality Compass® 2023 includes Healthcare Effectiveness Data and Information Set (HEDIS®) and Consumer Assessment of Healthcare Providers and Systems (CAHPS®) data. Any data display, analysis, interpretation, or conclusion based on these data is solely that of the authors. NCQA specifically disclaims responsibility for any such display, analysis, interpretation, or conclusion. Quality Compass and HEDIS are registered trademarks of NCQA. CAHPS® is a registered trademark of the Agency for Healthcare Research and Quality (AHRQ).
Users of the data shall not have the right to alter, enhance, or otherwise modify the data. Anyone who wants to use or reproduce the data without modification for a noncommercial purpose may do so without obtaining any approval from NCQA. All commercial uses must be approved by NCQA and are subject to a license at the discretion of NCQA. Use by healthcare providers in connection with their own practices is not commercial use. A "commercial use" refers to any sale, license, or distribution of the data for commercial gain, or incorporation of the data into any product or service that is sold, licensed, or distributed for commercial gain, even if there is no actual charge for inclusion of the data. ©2004-2023 National Committee for Quality Assurance, all rights reserved.